Utah Medical Products (UTMD) Gross Profit (2010 - 2026)

Utah Medical Products' Gross Profit history runs 17 years deep, the most recent figure standing at $5.3 million for Q1 2026.

• In Q1 2026, Gross Profit fell 4.62% year-over-year to $5.3 million; the TTM figure through Mar 2026 stood at $21.7 million (down 5.11% YoY), while the FY2025 annual figure was $22.0 million, down 8.87% from the prior year.
• Gross Profit was $5.3 million for Q1 2026 at Utah Medical Products, roughly flat from $5.3 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $8.3 million in Q4 2022 to a low of $5.3 million in Q4 2025.
• Historically, Gross Profit has averaged $6.7 million across 5 years, with a median of $6.8 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Gross Profit increased 8.44% in 2022, then dropped 25.01% in 2024.
• A 5-year view of Gross Profit shows it stood at $8.3 million in 2022, then decreased by 14.76% to $7.1 million in 2023, then decreased by 25.01% to $5.3 million in 2024, then dropped by 1.11% to $5.3 million in 2025, then increased by 0.34% to $5.3 million in 2026.
• The last three Gross Profit figures came in at $5.3 million (Q1 2026), $5.3 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.